electroCore, Inc. to Present at the Cantor Global Healthcare Conference

BASKING RIDGE, N.J., Sept. 18, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq:ECOR), a ...

Novartis real-world evidence confirms efficacy and safety benefits of Cosentyx® in daily life for psoriasis patients

Real-world evidence confirms Cosentyx® efficacy and safety consistent with previously reported clinical studies[1]-[4] Novartis ...

GILEAD EN GALAPAGOS KONDIGEN AAN DAT FILGOTINIB ALLE BELANGRIJKE ONDERZOEKSDOELEN HEEFT GEHAALD IN EERSTE REUMA FASE 3 STUDIE

                                         -- Doseringen van 100 mg en 200 mg filgotinib bereikten significant hogere ACR20/50/70 scores ...

Global Orphan Drug Pipeline & Regulatory Insight Report 2018

Dublin, Sept. 11, 2018 (GLOBE NEWSWIRE) -- The "Global Orphan Drug Pipeline & Regulatory ...

Flexion Therapeutics Announces Publication of Phase 2 Diabetes Data in September Issue of Rheumatology

Phase 2 data evaluating ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) in patients with Type ...

Flexion Therapeutics Announces Publication of Phase 2 Diabetes Data in September Issue of Rheumatology

Phase 2 data evaluating ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) in patients with Type ...